Contact this trialFirst, we need to learn more about you.
Enzyme Inhibitor
Devimistat + Chemoradiation for Pancreatic Cancer
Recruiting1 awardPhase 1
Detroit, Michigan
This trial is testing a new cancer drug CPI-613 in patients with pancreatic cancer. The goal is to find the maximum tolerated dose and learn about the safety profile.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.